BERKELEY, Calif., November 14, 2024--(BUSINESS WIRE)--Activate, the nonprofit fellowship where science entrepreneurs transform breakthrough ideas into advanced hard-tech companies, today announced a ...
Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced a significant milestone in its ongoing Phase 2 clinical study, ACTIVATE (clinicaltrials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback